Y Kawarada

754 total citations
26 papers, 592 citations indexed

About

Y Kawarada is a scholar working on Surgery, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, Y Kawarada has authored 26 papers receiving a total of 592 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Surgery, 7 papers in Pulmonary and Respiratory Medicine and 7 papers in Oncology. Recurrent topics in Y Kawarada's work include Hepatocellular Carcinoma Treatment and Prognosis (5 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (3 papers) and Cancer-related Molecular Pathways (3 papers). Y Kawarada is often cited by papers focused on Hepatocellular Carcinoma Treatment and Prognosis (5 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (3 papers) and Cancer-related Molecular Pathways (3 papers). Y Kawarada collaborates with scholars based in Japan, Egypt and United States. Y Kawarada's co-authors include Shunsuke Kondo, Tomoo Itoh, M Miyamoto, Ryuji Mizumoto, Hiroyuki Katoh, Kentaro Kato, S Okushiba, T. Yano, Takayuki Yamamoto and Takanori Kurokawa and has published in prestigious journals such as British Journal of Cancer, Peptides and Cancer Gene Therapy.

In The Last Decade

Y Kawarada

25 papers receiving 569 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Y Kawarada Japan 13 200 199 156 140 118 26 592
Morito Monden Japan 14 301 1.5× 137 0.7× 145 0.9× 86 0.6× 112 0.9× 19 635
Charles T. Miller United States 10 454 2.3× 117 0.6× 153 1.0× 104 0.7× 156 1.3× 15 705
Francine E. Carrick United States 9 308 1.5× 101 0.5× 134 0.9× 111 0.8× 105 0.9× 10 604
Masayuki Imamura Japan 16 230 1.1× 289 1.5× 370 2.4× 133 0.9× 131 1.1× 24 718
Krit Kitisin United States 12 360 1.8× 190 1.0× 261 1.7× 118 0.8× 95 0.8× 20 756
Toshinori Oka Japan 17 303 1.5× 109 0.5× 359 2.3× 155 1.1× 182 1.5× 47 777
Keizo Sugimachi Japan 10 234 1.2× 172 0.9× 187 1.2× 85 0.6× 133 1.1× 14 544
C. van Krimpen Netherlands 10 199 1.0× 89 0.4× 188 1.2× 175 1.3× 85 0.7× 21 640
Cristina López-Blau Spain 4 451 2.3× 96 0.5× 186 1.2× 98 0.7× 122 1.0× 5 766
Takesada Mori Japan 14 361 1.8× 215 1.1× 332 2.1× 88 0.6× 78 0.7× 29 799

Countries citing papers authored by Y Kawarada

Since Specialization
Citations

This map shows the geographic impact of Y Kawarada's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Y Kawarada with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Y Kawarada more than expected).

Fields of papers citing papers by Y Kawarada

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Y Kawarada. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Y Kawarada. The network helps show where Y Kawarada may publish in the future.

Co-authorship network of co-authors of Y Kawarada

This figure shows the co-authorship network connecting the top 25 collaborators of Y Kawarada. A scholar is included among the top collaborators of Y Kawarada based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Y Kawarada. Y Kawarada is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kogawa, Takahiro, Mototsugu Shimokawa, Tamer M. Fouad, et al.. (2014). Early skin toxicity predicts better outcomes, and early tumor shrinkage predicts better response after cetuximab treatment in advanced colorectal cancer. Targeted Oncology. 10(1). 125–133. 13 indexed citations
2.
Miyamoto, M, Liantao Li, M Kadoya, et al.. (2006). Immunohistochemical analysis of nuclear survivin expression in esophageal squamous cell carcinoma. Diseases of the Esophagus. 19(5). 355–359. 18 indexed citations
3.
Oshikiri, Taro, M Miyamoto, Kei Hiraoka, et al.. (2006). Transcriptional targeting of adenovirus vectors with the squamous cell carcinoma-specific antigen-2 promoter for selective apoptosis induction in lung cancer. Cancer Gene Therapy. 13(9). 856–863. 8 indexed citations
4.
Shichinohe, Toshiaki, Shunichi Okushiba, Toshiaki Morikawa, et al.. (2006). Salvage of a massive esophago-tracheal fistula resulting from a stenting treatment. Diseases of the Esophagus. 19(4). 299–304. 11 indexed citations
5.
Noji, Takehiro, Shunichi Okushiba, Shuji Kitashiro, et al.. (2005). Delayed esophageal reconstruction for aortoesophageal fistula caused by an aortic arch aneurysm with microvascular anastomosis of the left gastric artery and vein. Diseases of the Esophagus. 18(3). 204–206. 1 indexed citations
6.
Takahashi, Osamu, Shunichi Okushiba, Shunsuke Kondo, et al.. (2005). Esophageal pemphigus vulgaris with carcinoma: postoperative steroid therapy based on pemphigus-related antibodies. Diseases of the Esophagus. 18(6). 413–417. 5 indexed citations
7.
Miyamoto, M, Yuma Ebihara, Ryo Takahashi, et al.. (2005). Cyclin D1, E2F1 expression levels are associated with characteristics and prognosis of esophageal squamous cell carcinoma. Diseases of the Esophagus. 18(2). 109–113. 33 indexed citations
8.
Ebihara, Yuma, M Miyamoto, Akira Fukunaga, et al.. (2004). DARPP-32 expression arises after a phase of dysplasia in oesophageal squamous cell carcinoma. British Journal of Cancer. 91(1). 119–123. 26 indexed citations
9.
Ebihara, Yuma, M Miyamoto, Toshiaki Shichinohe, et al.. (2004). Over-expression of E2F-1 in esophageal squamous cell carcinoma correlates with tumor progression. Diseases of the Esophagus. 17(2). 150–154. 37 indexed citations
10.
Fukunaga, Akira, Shunichi Okushiba, Koichi Ohno, et al.. (2003). Mediastinal bronchial artery aneurysm with hematemesis. Diseases of the Esophagus. 16(4). 328–331. 19 indexed citations
11.
Kurokawa, Takanori, M Miyamoto, Kentaro Kato, et al.. (2003). Overexpression of hypoxia-inducible-factor 1α(HIF-1α) in oesophageal squamous cell carcinoma correlates with lymph node metastasis and pathologic stage. British Journal of Cancer. 89(6). 1042–1047. 130 indexed citations
12.
Ito, Seiki, et al.. (2001). Urinary Copper Excretion in Type 2 Diabetic Patients with Nephropathy. ˜The œNephron journals/Nephron journals. 88(4). 307–312. 51 indexed citations
13.
Masuda, Yutaka, Y Kawarada, & Toshihiro Sugiyama. (2000). Behavioral effect of mouse fibrinopeptide A on mouse forced swimming. Peptides. 21(4). 459–461. 7 indexed citations
14.
Kawarada, Y, H Ishikura, Takashi Kishimoto, et al.. (2000). The Role of Sialylated Lewis Antigens on Hematogeneous Metastases of Human Pancreas Carcinoma Cell Lines in vivo. Pathology - Research and Practice. 196(4). 259–263. 16 indexed citations
15.
Isaji, Shuji & Y Kawarada. (2000). [Evaluation of classification of pancreatic cancer by the Japan Pancreas Society and Union Internationale Contre le Cancer and proposal for a new international classification].. PubMed. 101(2). 205–11. 2 indexed citations
16.
Taoka, Hiroki & Y Kawarada. (1997). [Intrahepatic bile duct carcinoma (cholangiocarcinoma)].. PubMed. 98(5). 484–90. 11 indexed citations
17.
Yamamoto, Takayuki, et al.. (1991). Spontaneous rupture of hemangioma of the liver: treatment with transcatheter hepatic arterial embolization.. PubMed. 86(11). 1645–9. 70 indexed citations
18.
Kita, T, et al.. (1988). [Pathophysiology during follow-up after extensive pancreatectomy].. PubMed. 89(9). 1426–9. 3 indexed citations
19.
Kawarada, Y, et al.. (1986). Early carcinoma of the gallbladder, noninvasive carcinoma originating in the Rokitansky-Aschoff sinus: a case report.. PubMed. 81(1). 61–6. 43 indexed citations
20.
Kawarada, Y, Louca‐Mai Brady, & Takuya Matsumoto. (1974). Radiation injury to the large and small intestines.. PubMed. 25(6). 49–53. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Morito Monden Breakdown of academic impact, for papers by Charles T. Miller Breakdown of academic impact, for papers by Francine E. Carrick Breakdown of academic impact, for papers by Masayuki Imamura Breakdown of academic impact, for papers by Krit Kitisin Breakdown of academic impact, for papers by Toshinori Oka Breakdown of academic impact, for papers by Keizo Sugimachi Breakdown of academic impact, for papers by C. van Krimpen Breakdown of academic impact, for papers by Cristina López-Blau Breakdown of academic impact, for papers by Takesada Mori
Rankless by CCL
2026